Hope for a rare disease: eculizumab in neuromyelitis optica
- PMID: 23623398
- DOI: 10.1016/S1474-4422(13)70089-9
Hope for a rare disease: eculizumab in neuromyelitis optica
Comment on
-
Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study.Lancet Neurol. 2013 Jun;12(6):554-62. doi: 10.1016/S1474-4422(13)70076-0. Epub 2013 Apr 26. Lancet Neurol. 2013. PMID: 23623397
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
